Search

Search bills, members, committees and pages...

Sign In

NOVOCURE INC.

PreviousNext

33 federal lobbying filings, 2023 to 2026.

NOVOCURE INC. is a client on 33 federal lobbying filings, 2023 to 2026, reporting $1.3M across them. Oncology company with novel therapy for solid tumors Based in Pennsylvania.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.

Firms

3 it has hired, by filings.

RegistrantFilingsReported
NOVOCURE INC.15—
TARPLIN, DOWNS & YOUNG, LLC14$1.1M
WILLIAMS AND JENSEN, PLLC4$180K

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20266$280K$340K
202510$380K$440K
20248$320K$650K
20239$320K$670K

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
MMMMedicare/Medicaid32
HCRHealth Issues14
VETVeterans11
PHAPharmacy4
TARTariff (miscellaneous tariff bills)3
TRATransportation3
BUDBudget/Appropriations1

Bills

The bills the filings name, by how many name them.

BillTitleFilings
S. 1717Ensuring Patient Access to Critical Breakthrough Products Act of 20259
H.R. 5343Ensuring Patient Access to Critical Breakthrough Products Act8
H.R. 1691Employee Business Expense Deduction Reinstatement Act of 20251
S. 5349DEPOTS Act1

Lobbyists

Named on the filings.

LobbyistClientsFilings
KATHERINE MEYER115
CHARLOTTE IVANCIC114
ELIZABETH MURRAY114
EMILY MURRY114
JENNIFER YOUNG114
MARGARET JOSEPH114
PAMELA SMITH114
ZARIA SMITH113
ELLE WHITSON18
KIMBERLY BRANDT18
LAURA FRIEDEL18
PETER FISE18
RAISSA DOWNS18
JEANNE HAGGERTY14
LAURA WINTERS14
MELINDA MAXFIELD14
ROBERT BUTORA14
SUSAN HIRSCHMANN14
DANIEL ZIEGLER13
EMILY HAAS13
JOSHUA FENDRICK13
PARICK CARROLL13
KURT SCHRADER11
LAURA SIMMONS11

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
NOVOCURE INC.WILLIAMS AND JENSEN, PLLC2026 second_quarter$60KJul 20, 2026
NOVOCURE INC.TARPLIN, DOWNS & YOUNG, LLC2026 second_quarter$80KJul 20, 2026
NOVOCURE INC.NOVOCURE INC.2026 second_quarter$160KJul 19, 2026
NOVOCURE INC.TARPLIN, DOWNS & YOUNG, LLC2026 first_quarter$80KApr 20, 2026
NOVOCURE INC.WILLIAMS AND JENSEN, PLLC2026 first_quarter$60KApr 20, 2026
NOVOCURE INC.NOVOCURE INC.2026 first_quarter$180KApr 20, 2026
NOVOCURE INC.TARPLIN, DOWNS & YOUNG, LLC2025 fourth_quarter$80KJan 20, 2026
NOVOCURE INC.WILLIAMS AND JENSEN, PLLC2025 fourth_quarter$60KJan 20, 2026
NOVOCURE INC.NOVOCURE INC.2025 fourth_quarter$110KJan 17, 2026
NOVOCURE INC.WILLIAMS AND JENSEN, PLLC2025 fourth_quarter—Nov 20, 2025
NOVOCURE INC.TARPLIN, DOWNS & YOUNG, LLC2025 third_quarter$80KOct 15, 2025
NOVOCURE INC.NOVOCURE INC.2025 third_quarter$110KOct 14, 2025
NOVOCURE INC.TARPLIN, DOWNS & YOUNG, LLC2025 second_quarter$80KJul 17, 2025
NOVOCURE INC.NOVOCURE INC.2025 second_quarter$110KJul 15, 2025
NOVOCURE INC.TARPLIN, DOWNS & YOUNG, LLC2025 first_quarter$80KApr 21, 2025
NOVOCURE INC.NOVOCURE INC.2025 first_quarter$110KApr 16, 2025
NOVOCURE INC.TARPLIN, DOWNS & YOUNG, LLC2024 fourth_quarter$80KJan 16, 2025
NOVOCURE INC.NOVOCURE INC.2024 fourth_quarter$110KJan 14, 2025
NOVOCURE INC.TARPLIN, DOWNS & YOUNG, LLC2024 third_quarter$80KOct 18, 2024
NOVOCURE INC.NOVOCURE INC.2024 third_quarter$120KOct 15, 2024
NOVOCURE INC.NOVOCURE INC.2024 second_quarter$220KJul 22, 2024
NOVOCURE INC.TARPLIN, DOWNS & YOUNG, LLC2024 second_quarter$80KJul 16, 2024
NOVOCURE INC.NOVOCURE INC.2024 first_quarter$200KApr 22, 2024
NOVOCURE INC.TARPLIN, DOWNS & YOUNG, LLC2024 first_quarter$80KApr 16, 2024
NOVOCURE INC.TARPLIN, DOWNS & YOUNG, LLC2023 fourth_quarter$80KJan 18, 2024